News

A bipartisan group of lawmakers on Monday unveiled its $908 billion coronavirus relief package as Congress faces a time crunch to pass more aid.

A $908 billion bipartisan COVID-19 relief plan set to be introduced in the U.S. Congress as early as Monday will be split into two packages in a bid to win approval, a person briefed on the matter said.

Cargo planes and trucks with the first U.S. shipments of coronavirus vaccine fanned out from FedEx and UPS hubs in Tennessee and Kentucky on Sunday en route to distribution points around the country, launching an immunization project of unprecedented scope and complexity.

An important federal advisory committee at the Centers for Disease Control and Prevention has added its vote of support for the Pfizer-BioNTech COVID-19 vaccine.

Unsustainable reimbursement model risks patient access

Worldwide coronavirus cases crossed 40 million on Monday, according to a Reuters tally, as the onset of winter in the northern hemisphere fuelled a resurgence in the spread of the disease.

Washington's inability to pass a much-needed stimulus bill ahead of November's election is expected to inflict further damage on the economy, potentially kneecapping its recovery as the expiration of key benefits looms.

Democrats have already dismissed the GOP approach as inadequate, and are not expected to support the proposals.

Coronavirus cases are rising rapidly in many states as the U.S. heads into the winter months. And forecasters predict staggering growth in infections and deaths if current trends continue.

Pharmacists in all 50 states are now allowed to give childhood vaccinations under a new directive aimed at preventing future outbreaks of measles and other preventable diseases.